Nikos E. Tsopanoglou

1.1k total citations
27 papers, 832 citations indexed

About

Nikos E. Tsopanoglou is a scholar working on Hematology, Molecular Biology and Internal Medicine. According to data from OpenAlex, Nikos E. Tsopanoglou has authored 27 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 11 papers in Molecular Biology and 7 papers in Internal Medicine. Recurrent topics in Nikos E. Tsopanoglou's work include Blood Coagulation and Thrombosis Mechanisms (17 papers), Angiogenesis and VEGF in Cancer (7 papers) and Protease and Inhibitor Mechanisms (7 papers). Nikos E. Tsopanoglou is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (17 papers), Angiogenesis and VEGF in Cancer (7 papers) and Protease and Inhibitor Mechanisms (7 papers). Nikos E. Tsopanoglou collaborates with scholars based in Greece, United States and Spain. Nikos E. Tsopanoglou's co-authors include Michael E. Maragoudakis, Christodoulos Flordellis, Paraskevi Andriopoulou, George C. Haralabopoulos, Jennifer L. Strande, George Karakiulakis, Eva Pipili‐Synetos, Konstantinos Katsanos, Roberto F. Nicosia and Helen Papadaki and has published in prestigious journals such as Journal of Biological Chemistry, FEBS Letters and Kidney International.

In The Last Decade

Nikos E. Tsopanoglou

27 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nikos E. Tsopanoglou Greece 18 379 362 201 125 114 27 832
Xuesheng Feng United States 9 395 1.0× 241 0.7× 238 1.2× 186 1.5× 87 0.8× 10 721
Hartmut Weiler-Guettler United States 9 422 1.1× 300 0.8× 109 0.5× 94 0.8× 152 1.3× 9 828
L L Leung United States 9 686 1.8× 335 0.9× 304 1.5× 133 1.1× 35 0.3× 11 1.1k
Paraskevi Andriopoulou Greece 7 116 0.3× 461 1.3× 116 0.6× 49 0.4× 37 0.3× 8 815
Elizabeth B. Kelso United Kingdom 8 595 1.6× 134 0.4× 259 1.3× 311 2.5× 24 0.2× 11 921
T K Vu United States 10 1.1k 3.0× 388 1.1× 304 1.5× 510 4.1× 80 0.7× 10 1.5k
Morley D. Hollenberg Canada 15 849 2.2× 291 0.8× 274 1.4× 611 4.9× 27 0.2× 20 1.3k
Sarah L. Tressel United States 11 124 0.3× 474 1.3× 175 0.9× 47 0.4× 26 0.2× 13 1.0k
Olivier Calvayrac France 15 114 0.3× 430 1.2× 212 1.1× 32 0.3× 39 0.3× 24 875
Reinhard Kelsch Germany 16 105 0.3× 518 1.4× 227 1.1× 61 0.5× 54 0.5× 33 1.1k

Countries citing papers authored by Nikos E. Tsopanoglou

Since Specialization
Citations

This map shows the geographic impact of Nikos E. Tsopanoglou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikos E. Tsopanoglou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikos E. Tsopanoglou more than expected).

Fields of papers citing papers by Nikos E. Tsopanoglou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikos E. Tsopanoglou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikos E. Tsopanoglou. The network helps show where Nikos E. Tsopanoglou may publish in the future.

Co-authorship network of co-authors of Nikos E. Tsopanoglou

This figure shows the co-authorship network connecting the top 25 collaborators of Nikos E. Tsopanoglou. A scholar is included among the top collaborators of Nikos E. Tsopanoglou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikos E. Tsopanoglou. Nikos E. Tsopanoglou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tato, Francisco, et al.. (2013). Highly functionalized 2-oxopiperazine-based peptidomimetics: An approach to PAR1 antagonists. European Journal of Medicinal Chemistry. 70. 199–224. 5 indexed citations
2.
Katsanos, Konstantinos, Ioannis Lilis, Helen Papadaki, et al.. (2013). NGF Promotes Hemodynamic Recovery in a Rabbit Hindlimb Ischemic Model Through trkA- and VEGFR2-dependent Pathways. Journal of Cardiovascular Pharmacology. 62(3). 270–277. 15 indexed citations
3.
Rutz, Claudia, Jens Furkert, Antje Schmidt, et al.. (2012). The protease‐activated receptor 1 possesses a functional and cleavable signal peptide which is necessary for receptor expression. FEBS Letters. 586(16). 2351–2359. 16 indexed citations
4.
López, Manuela G., et al.. (2012). Design, synthesis and biological evaluation of new peptide-based ureas and thioureas as potential antagonists of the thrombin receptor PAR1. European Journal of Medicinal Chemistry. 58. 98–111. 10 indexed citations
5.
Διαμαντόπουλος, Αθανάσιος, Iason Kyriazis, Helen Papadaki, et al.. (2012). Parstatin Prevents Renal Injury following Ischemia/Reperfusion and Radiocontrast Administration. American Journal of Nephrology. 36(3). 278–286. 8 indexed citations
6.
Hu, Huang, Xiufeng Zhong, JiKui Shen, et al.. (2010). Parstatin Suppresses Ocular Neovascularization and Inflammation. Investigative Ophthalmology & Visual Science. 51(11). 5825–5825. 15 indexed citations
7.
Tsopanoglou, Nikos E. & Michael E. Maragoudakis. (2009). Thrombin's central role in angiogenesis and pathophysiological processes. European Cytokine Network. 20(4). 171–179. 28 indexed citations
8.
Tsopanoglou, Nikos E., et al.. (2009). Parstatin(1-26): The Putative Signal Peptide of Protease-Activated Receptor 1 Confers Potent Protection from Myocardial Ischemia-Reperfusion Injury. Journal of Pharmacology and Experimental Therapeutics. 332(3). 898–905. 20 indexed citations
9.
Katsanos, Konstantinos, Dimitrios Karnabatidis, Αθανάσιος Διαμαντόπουλος, et al.. (2009). Thrombin promotes arteriogenesis and hemodynamic recovery in a rabbit hindlimb ischemia model. Journal of Vascular Surgery. 49(4). 1000–1012. 15 indexed citations
10.
Aplin, Alfred C., et al.. (2008). Parstatin, the Cleaved Peptide on Proteinase-Activated Receptor 1 Activation, Is a Potent Inhibitor of Angiogenesis. Journal of Pharmacology and Experimental Therapeutics. 328(2). 378–389. 28 indexed citations
11.
Flordellis, Christodoulos, et al.. (2008). Thrombin mediates mitogenesis and survival of human endothelial cells through distinct mechanisms. American Journal of Physiology-Cell Physiology. 294(5). C1215–C1226. 21 indexed citations
12.
Flordellis, Christodoulos, et al.. (2006). Blockade of Angiogenesis by Small Molecule Antagonists to Protease-Activated Receptor-1: Association with Endothelial Cell Growth Suppression and Induction of Apoptosis. Journal of Pharmacology and Experimental Therapeutics. 318(1). 246–254. 37 indexed citations
13.
Carrell, Christopher J., Agustin O. Pineda, F. Scott Mathews, et al.. (2005). Thrombin Functions through Its RGD Sequence in a Non-canonical Conformation. Journal of Biological Chemistry. 280(33). 29393–29396. 29 indexed citations
14.
Tsopanoglou, Nikos E. & Michael E. Maragoudakis. (2004). Role of Thrombin in Angiogenesis and Tumor Progression. Seminars in Thrombosis and Hemostasis. 30(1). 63–69. 97 indexed citations
15.
Tsopanoglou, Nikos E., et al.. (2004). On the mode of action of thrombin-induced angiogenesis: thrombin peptide, TP508, mediates effects in endothelial cells via αvβ3 integrin. Thrombosis and Haemostasis. 92(10). 846–857. 29 indexed citations
16.
Maragoudakis, Michael E., et al.. (2000). Effects of thrombin/thrombosis in angiogenesis and tumour progression. Matrix Biology. 19(4). 345–351. 52 indexed citations
17.
Maragoudakis, Michael E. & Nikos E. Tsopanoglou. (2000). On the Mechanism(s) of Thrombin Induced Angiogenesis. Advances in experimental medicine and biology. 476. 47–55. 21 indexed citations
18.
Tsopanoglou, Nikos E. & Michael E. Maragoudakis. (1999). On the Mechanism of Thrombin-induced Angiogenesis. Journal of Biological Chemistry. 274(34). 23969–23976. 181 indexed citations
19.
Tsopanoglou, Nikos E. & Nikos E. Tsopanoglou. (1997). On the mechanism of thrombin-induced angiogenesis: inhibition of attachment of endothelial cells on basement membrane components. Angiogenesis. 1(2). 192–200. 17 indexed citations
20.
Maragoudakis, Michael E., et al.. (1993). Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties. Kidney International. 43(1). 147–150. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuesheng Feng Breakdown of academic impact, for papers by Hartmut Weiler-Guettler Breakdown of academic impact, for papers by L L Leung Breakdown of academic impact, for papers by Paraskevi Andriopoulou Breakdown of academic impact, for papers by Elizabeth B. Kelso Breakdown of academic impact, for papers by T K Vu Breakdown of academic impact, for papers by Morley D. Hollenberg Breakdown of academic impact, for papers by Sarah L. Tressel Breakdown of academic impact, for papers by Olivier Calvayrac Breakdown of academic impact, for papers by Reinhard Kelsch
Rankless by CCL
2026